|
Search
Collections
Benchmarks
Upload document
CC-486
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 product
1 abstract
Abstract
Results from a phase (Ph) 1 clinical study of the all-oral regimen of CC-486 and venetoclax for acute myeloid leukemia (AML).
Org:
University of Colorado, Aurora, CO,
Product
CC-486 + PEMBRO